Articles from Lowey Dannenberg, P.C.

NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Edison International (“Edison” or the “Company”) (NYSEEIX) for violations of the federal securities laws on behalf of investors who purchased or acquired Edison common stock between February 25, 2021 and February 6, 2025, inclusive (the “Class Period”).

NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Neumora Therapeutics, Inc. (“Neumora” or the “Company”) (NASDAQNMRA) for violations of the federal securities laws on behalf of investors who purchased or acquired Neumora common stock at the time of the Company’s Initial Public Offering (“IPO”) on September 15, 2023.

NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQTMDX) for violations of the federal securities laws on behalf of investors who purchased or acquired TransMedics common stock between February 28, 2023 and January 10, 2025, inclusive (the “Class Period”).

NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Venture Global, Inc. (“Venture Global” or the “Company”) (NYSEVG) for violations of the federal securities laws on behalf of investors who purchased or acquired Venture Global common stock at the time of the Company’s Initial Public Offering (“IPO”) on January 24, 2025.

NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Integral Ad Science Holding Corp. (“IAS” or the “Company”) (NASDAQIAS) for violations of the federal securities laws on behalf of investors who purchased or acquired IAS common stock between March 2, 2023, and February 27, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Crocs, Inc. (“Crocs” or the “Company”) (NASDAQCROX) for violations of the federal securities laws on behalf of investors who purchased or acquired Crocs common stock between November 3, 2022, and October 28, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Pacira Biosciences, Inc. (“Pacira” or the “Company”) (NASDAQPCRX) for violations of the federal securities laws on behalf of investors who purchased or acquired Pacira common stock between August 2, 2023 to August 8, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against FTAI Aviation Ltd. (“FTAI” or the “Company”) (NASDAQFTAI) for violations of the federal securities laws on behalf of investors who purchased or acquired FTAI common stock between July 23, 2024 and January 15, 2025, inclusive (the “Class Period”).

NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Novo Nordisk A/S (“Novo” or the “Company”) (NYSENVO) for violations of the federal securities laws on behalf of investors who purchased or acquired Novo common stock between November 2, 2022 to December 19, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQTMDX) for violations of the federal securities laws on behalf of investors who purchased or acquired TransMedics common stock between February 28, 2023 and January 10, 2025, inclusive (the “Class Period”).

NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Venture Global, Inc. (“Venture Global” or the “Company”) (NYSEVG) for violations of the federal securities laws on behalf of investors who purchased or acquired Venture Global common stock at the time of the Company’s Initial Public Offering (“IPO”) on January 24, 2025.

NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Integral Ad Science Holding Corp. (“IAS” or the “Company”) (NASDAQIAS) for violations of the federal securities laws on behalf of investors who purchased or acquired IAS common stock between March 2, 2023, and February 27, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Pacira Biosciences, Inc. (“Pacira” or the “Company”) (NASDAQPCRX) for violations of the federal securities laws on behalf of investors who purchased or acquired Pacira common stock between August 2, 2023 to August 8, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Crocs, Inc. (“Crocs” or the “Company”) (NASDAQCROX) for violations of the federal securities laws on behalf of investors who purchased or acquired Crocs common stock between November 3, 2022, and October 28, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Neumora Therapeutics, Inc. (“Neumora” or the “Company”) (NASDAQNMRA) for violations of the federal securities laws on behalf of investors who purchased or acquired Neumora common stock at the time of the Company’s Initial Public Offering (“IPO”) on September 15, 2023.

NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against FTAI Aviation Ltd. (“FTAI” or the “Company”) (NASDAQFTAI) for violations of the federal securities laws on behalf of investors who purchased or acquired FTAI common stock between July 23, 2024 and January 15, 2025, inclusive (the “Class Period”).

NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Novo Nordisk A/S (“Novo” or the “Company”) (NYSENVO) for violations of the federal securities laws on behalf of investors who purchased or acquired Novo common stock between November 2, 2022 to December 19, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against FTAI Aviation Ltd. (“FTAI” or the “Company”) (NASDAQFTAI) for violations of the federal securities laws on behalf of investors who purchased or acquired FTAI common stock between July 23, 2024 and January 15, 2025, inclusive (the “Class Period”).

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Pacira Biosciences, Inc. (“Pacira” or the “Company”) (NASDAQPCRX) for violations of the federal securities laws on behalf of investors who purchased or acquired Pacira common stock between August 2, 2023 to August 8, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Crocs, Inc. (“Crocs” or the “Company”) (NASDAQCROX) for violations of the federal securities laws on behalf of investors who purchased or acquired Crocs common stock between November 3, 2022, and October 28, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Novo Nordisk A/S (“Novo” or the “Company”) (NYSENVO) for violations of the federal securities laws on behalf of investors who purchased or acquired Novo common stock between November 2, 2022 to December 19, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Neumora Therapeutics, Inc. (“Neumora” or the “Company”) (NASDAQNMRA) for violations of the federal securities laws on behalf of investors who purchased or acquired Neumora common stock at the time of the Company’s Initial Public Offering (“IPO”) on September 15, 2023.

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating TransMedics Group, Inc. (“TransMedics”) (NASDAQTMDX) for potential violations of the federal securities laws.

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Edison International (“Edison” or the “Company”) (NYSEEIX) for violations of the federal securities laws on behalf of investors who purchased or acquired Edison common stock between February 25, 2021 and February 6, 2025, inclusive (the “Class Period”).

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Integral Ad Science Holding Corp. (“IAS” or the “Company”) (NASDAQIAS) for violations of the federal securities laws on behalf of investors who purchased or acquired IAS common stock between March 2, 2023, and February 27, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against FTAI Aviation Ltd. (“FTAI” or the “Company”) (NASDAQFTAI) for violations of the federal securities laws on behalf of investors who purchased or acquired FTAI common stock between July 23, 2024 and January 15, 2025, inclusive (the “Class Period”).

NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Pacira Biosciences, Inc. (“Pacira” or the “Company”) (NASDAQPCRX) for violations of the federal securities laws on behalf of investors who purchased or acquired Pacira common stock between August 2, 2023 to August 8, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Crocs, Inc. (“Crocs” or the “Company”) (NASDAQCROX) for violations of the federal securities laws on behalf of investors who purchased or acquired Crocs common stock between November 3, 2022, and October 28, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Novo Nordisk A/S (“Novo” or the “Company”) (NYSENVO) for violations of the federal securities laws on behalf of investors who purchased or acquired Novo common stock between November 2, 2022 to December 19, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Neumora Therapeutics, Inc. (“Neumora” or the “Company”) (NASDAQNMRA) for violations of the federal securities laws on behalf of investors who purchased or acquired Neumora common stock at the time of the Company’s Initial Public Offering (“IPO”) on September 15, 2023.

NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating TransMedics Group, Inc. (“TransMedics”) (NASDAQTMDX) for potential violations of the federal securities laws.

NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Edison International (“Edison” or the “Company”) (NYSEEIX) for violations of the federal securities laws on behalf of investors who purchased or acquired Edison common stock between February 25, 2021 and February 6, 2025, inclusive (the “Class Period”).

NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Integral Ad Science Holding Corp. (“IAS” or the “Company”) (NASDAQIAS) for violations of the federal securities laws on behalf of investors who purchased or acquired IAS common stock between March 2, 2023, and February 27, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against FTAI Aviation Ltd. (“FTAI” or the “Company”) (NASDAQFTAI) for violations of the federal securities laws on behalf of investors who purchased or acquired FTAI common stock between July 23, 2024 and January 15, 2025, inclusive (the “Class Period”).

NEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Pacira Biosciences, Inc. (“Pacira” or the “Company”) (NASDAQPCRX) for violations of the federal securities laws on behalf of investors who purchased or acquired Pacira common stock between August 2, 2023 to August 8, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQAZN) for violations of the federal securities laws on behalf of investors who purchased or acquired AstraZeneca common stock between February 23, 2022 and December 17, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Crocs, Inc. (“Crocs” or the “Company”) (NASDAQCROX) for violations of the federal securities laws on behalf of investors who purchased or acquired Crocs common stock between November 3, 2022, and October 28, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Novo Nordisk A/S (“Novo” or the “Company”) (NYSENVO) for violations of the federal securities laws on behalf of investors who purchased or acquired Novo common stock between November 2, 2022 to December 19, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating TransMedics Group, Inc. (“TransMedics”) (NASDAQTMDX) for potential violations of the federal securities laws.

NEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Integral Ad Science Holding Corp. (“IAS” or the “Company”) (NASDAQIAS) for violations of the federal securities laws on behalf of investors who purchased or acquired IAS common stock between March 2, 2023, and February 27, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Pacira Biosciences, Inc. (“Pacira” or the “Company”) (NASDAQPCRX) for violations of the federal securities laws on behalf of investors who purchased or acquired Pacira common stock between August 2, 2023 to August 8, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQAZN) for violations of the federal securities laws on behalf of investors who purchased or acquired AstraZeneca common stock between February 23, 2022 and December 17, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Crocs, Inc. (“Crocs” or the “Company”) (NASDAQCROX) for violations of the federal securities laws on behalf of investors who purchased or acquired Crocs common stock between November 3, 2022, and October 28, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Novo Nordisk A/S (“Novo” or the “Company”) (NYSENVO) for violations of the federal securities laws on behalf of investors who purchased or acquired Novo common stock between November 2, 2022 to December 19, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating TransMedics Group, Inc. (“TransMedics”) (NASDAQTMDX) for potential violations of the federal securities laws.

NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against FTAI Aviation Ltd. (“FTAI” or the “Company”) (NASDAQFTAI) for violations of the federal securities laws on behalf of investors who purchased or acquired FTAI common stock between July 23, 2024 and January 15, 2025, inclusive (the “Class Period”).

NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Pacira Biosciences, Inc. (“Pacira” or the “Company”) (NASDAQPCRX) for violations of the federal securities laws on behalf of investors who purchased or acquired Pacira common stock between August 2, 2023 to August 8, 2024, inclusive (the “Class Period”).

NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQAZN) for violations of the federal securities laws on behalf of investors who purchased or acquired AstraZeneca common stock between February 23, 2022 and December 17, 2024, inclusive (the “Class Period”).

NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Crocs, Inc. (“Crocs” or the “Company”) (NASDAQCROX) for violations of the federal securities laws on behalf of investors who purchased or acquired Crocs common stock between November 3, 2022, and October 28, 2024, inclusive (the “Class Period”).

NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Novo Nordisk A/S (“Novo” or the “Company”) (NYSENVO) for violations of the federal securities laws on behalf of investors who purchased or acquired Novo common stock between November 2, 2022 to December 19, 2024, inclusive (the “Class Period”).

NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against FTAI Aviation Ltd. (“FTAI” or the “Company”) (NASDAQFTAI) for violations of the federal securities laws on behalf of investors who purchased or acquired FTAI common stock between July 23, 2024 and January 15, 2025, inclusive (the “Class Period”).

NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Pacira Biosciences, Inc. (“Pacira” or the “Company”) (NASDAQPCRX) for violations of the federal securities laws on behalf of investors who purchased or acquired Pacira common stock between August 2, 2023 to August 8, 2024, inclusive (the “Class Period”).

NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Five9, Inc. (“Five9” or the “Company”) (NASDAQFIVN) for violations of the federal securities laws on behalf of investors who purchased or acquired Five9 common stock between June 4, 2024, and August 8, 2024, inclusive (the “Class Period”).

NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQAZN) for violations of the federal securities laws on behalf of investors who purchased or acquired AstraZeneca common stock between February 23, 2022 and December 17, 2024, inclusive (the “Class Period”).

NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against FTAI Aviation Ltd. (“FTAI” or the “Company”) (NASDAQFTAI) for violations of the federal securities laws on behalf of investors who purchased or acquired FTAI common stock between July 23, 2024 and January 15, 2025, inclusive (the “Class Period”).

NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Customers Bancorp, Inc. (“Customers Bancorp” or the “Company”) (NYSECUBI) for violations of the federal securities laws on behalf of investors who purchased or acquired Customers Bancorp common stock between March 1, 2024 and August 8, 2024, inclusive (the “Class Period”).

NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQASPI) for violations of the federal securities laws on behalf of investors who purchased or acquired ASP Isotopes common stock between October 30, 2024 and November 26, 2024, inclusive (the “Class Period”).

NEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Pacira Biosciences, Inc. (“Pacira” or the “Company”) (NASDAQPCRX) for violations of the federal securities laws on behalf of investors who purchased or acquired Pacira common stock between August 2, 2023 to August 8, 2024, inclusive (the “Class Period”).

NEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Five9, Inc. (“Five9” or the “Company”) (NASDAQFIVN) for violations of the federal securities laws on behalf of investors who purchased or acquired Five9 common stock between June 4, 2024, and August 8, 2024, inclusive (the “Class Period”).

NEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Rentokil Initial PLC (“Rentokil” or the “Company”) (NYSERTO) for violations of the federal securities laws on behalf of investors who purchased or acquired Rentokil common stock between December 1, 2023 and September 10, 2024, inclusive (the “Class Period”).

NEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQAZN) for violations of the federal securities laws on behalf of investors who purchased or acquired AstraZeneca common stock between February 23, 2022 and December 17, 2024, inclusive (the “Class Period”).

NEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Customers Bancorp, Inc. (“Customers Bancorp” or the “Company”) (NYSECUBI) for violations of the federal securities laws on behalf of investors who purchased or acquired Customers Bancorp common stock between March 1, 2024 and August 8, 2024, inclusive (the “Class Period”).

NEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQASPI) for violations of the federal securities laws on behalf of investors who purchased or acquired ASP Isotopes common stock between October 30, 2024 and November 26, 2024, inclusive (the “Class Period”).

NEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Dentsply Sirona Inc. (“Dentsply Sirona,” “Dentsply,” or the “Company”) (NASDAQXRAY) for violations of the federal securities laws on behalf of investors who purchased or acquired Dentsply Sirona common stock between December 1, 2022 and November 6 2024, inclusive (the “Class Period”).

NEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Zeta Global Holdings Corp. (“Zeta” or the “Company”) (NYSEZETA) for violations of the federal securities laws on behalf of investors who purchased or acquired Zeta common stock between February 27, 2024 and November 13, 2024, inclusive (the “Class Period”).

NEW YORK, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Five9, Inc. (“Five9” or the “Company”) (NASDAQFIVN) for violations of the federal securities laws on behalf of investors who purchased or acquired Five9 common stock between June 4, 2024, and August 8, 2024, inclusive (the “Class Period”).

NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Rentokil Initial PLC (“Rentokil” or the “Company”) (NYSERTO) for violations of the federal securities laws on behalf of investors who purchased or acquired Rentokil common stock between December 1, 2023 and September 10, 2024, inclusive (the “Class Period”).

NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQAZN) for violations of the federal securities laws on behalf of investors who purchased or acquired AstraZeneca common stock between February 23, 2022 and December 17, 2024, inclusive (the “Class Period”).

NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQASPI) for violations of the federal securities laws on behalf of investors who purchased or acquired ASP Isotopes common stock between October 30, 2024 and November 26, 2024, inclusive (the “Class Period”).

NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Customers Bancorp, Inc. (“Customers Bancorp” or the “Company”) (NYSECUBI) for violations of the federal securities laws on behalf of investors who purchased or acquired Customers Bancorp common stock between March 1, 2024 and August 8, 2024, inclusive (the “Class Period”).

NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Dentsply Sirona Inc. (“Dentsply Sirona,” “Dentsply,” or the “Company”) (NASDAQXRAY) for violations of the federal securities laws on behalf of investors who purchased or acquired Dentsply Sirona common stock between December 1, 2022 and November 6 2024, inclusive (the “Class Period”).

NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Zeta Global Holdings Corp. (“Zeta” or the “Company”) (NYSEZETA) for violations of the federal securities laws on behalf of investors who purchased or acquired Zeta common stock between February 27, 2024 and November 13, 2024, inclusive (the “Class Period”).

NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- ZoomInfo Technologies (“ZoomInfo” or the “Company”) is a Delaware company headquartered in Vancouver, Washington. ZoomInfo is a subscription-based software company that sells access to its database of information about businesspeople and companies to sales, marketing and recruiting professionals.

NEW YORK, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQAZN) for violations of the federal securities laws on behalf of investors who purchased or acquired AstraZeneca common stock between February 23, 2022 and December 17, 2024, inclusive (the “Class Period”).

NEW YORK, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQASPI) for violations of the federal securities laws on behalf of investors who purchased or acquired ASP Isotopes common stock between October 30, 2024 and November 26, 2024, inclusive (the “Class Period”).